DENKHAUS DONALD A
Insider CIK 1278439 · CPRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 23,248 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 29,524 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 15,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 30,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 33,500 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 5,468 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,894 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,414 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 18,115 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer | 2026-07-15 | 2026-07-17 | 498,773 | $31.50 | $15.71M | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 178,163 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 498,773 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 179,497 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 497,439 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 180,910 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 496,026 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 5,468 | — | $0 | 181,857 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 18,115 | — | $0 | 176,389 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 158,274 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 495,079 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-01-08 | 2025-01-10 | 50,000 | — | $0 | 162,274 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-01-08 | 2025-01-10 | 50,000 | $2.24 | $112.0K | 491,079 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-27 | 2024-12-31 | 1,333 | — | $0 | 212,274 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-27 | 2024-12-31 | 1,333 | — | $0 | 441,079 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-09 | 2024-12-11 | 1,413 | — | $0 | 213,607 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-09 | 2024-12-11 | 1,413 | — | $0 | 439,746 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 23,248 | — | $0 | 212,179 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 2,841 | — | $0 | 215,020 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-02-15 | 2024-02-16 | 4,000 | — | $0 | 188,931 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-02-15 | 2024-02-16 | 4,000 | — | $0 | 438,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-02-05 | 2024-02-06 | 40,000 | — | $0 | 192,931 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-02-05 | 2024-02-06 | 40,000 | $4.01 | $160.4K | 434,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-27 | 2023-12-29 | 1,333 | — | $0 | 232,931 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-27 | 2023-12-29 | 1,333 | — | $0 | 394,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 4,240 | — | $0 | 234,264 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 29,524 | — | $0 | 230,024 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-08-03 | 2023-08-04 | 60,000 | — | $0 | 200,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-08-03 | 2023-08-04 | 60,000 | $1.13 | $67.8K | 393,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-02-15 | 2023-02-17 | 4,000 | — | $0 | 260,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-02-15 | 2023-02-17 | 4,000 | — | $0 | 333,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-01-24 | 2023-01-27 | 50,000 | — | $0 | 264,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-01-24 | 2023-01-27 | 50,000 | $0.79 | $39.5K | 329,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 15,000 | — | $0 | 310,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 4,000 | — | $0 | 314,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-12-06 | 2022-12-08 | 1,334 | — | $0 | 295,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-12-06 | 2022-12-08 | 1,334 | — | $0 | 279,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-11-11 | 2022-11-15 | 20,000 | $16.59 | $331.8K | 277,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-09-14 | 2022-09-15 | 20,000 | $15.34 | $306.8K | 297,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-02-14 | 2022-02-16 | 12,000 | — | $0 | 296,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-01-10 | 2022-01-11 | 40,000 | — | $0 | 284,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-01-10 | 2022-01-11 | 40,000 | $2.53 | $101.2K | 317,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-01-05 | 2022-01-06 | 50,000 | — | $0 | 324,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-01-05 | 2022-01-06 | 50,000 | $3.35 | $167.5K | 277,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-12-28 | 2021-12-30 | 20,000 | — | $0 | 374,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-12-03 | 2021-12-06 | 1,333 | — | $0 | 354,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-12-03 | 2021-12-06 | 1,333 | — | $0 | 227,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2020-12-30 | 2021-01-04 | 30,000 | — | $0 | 356,167 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2020-12-22 | 2020-12-23 | 1,333 | — | $0 | 326,167 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2020-12-22 | 2020-12-23 | 1,333 | — | $0 | 226,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 4,000 | — | $0 | 327,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 33,500 | — | $0 | 323,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2018-12-27 | 2018-12-28 | 25,000 | $1.91 | $47.8K | 225,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 25,000 | — | $0 | 290,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 25,000 | — | $0 | 265,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2018-12-14 | 2018-12-17 | 60,000 | $2.48 | $148.8K | 200,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2018-06-08 | 2018-06-11 | 20,000 | $3.41 | $68.2K | 140,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2018-05-30 | 2018-05-31 | 20,000 | $3.75 | $75.0K | 120,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 20,000 | — | $0 | 240,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 20,000 | — | $0 | 220,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 30,000 | — | $0 | 200,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 30,000 | — | $0 | 170,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 25,000 | — | $0 | 115,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 25,000 | — | $0 | 140,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2016-06-14 | 2016-06-14 | 50,000 | $0.65 | $32.5K | 100,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2016-01-07 | 2016-01-07 | 25,000 | $2.03 | $50.7K | 50,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 20,000 | — | $0 | 90,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 20,000 | — | $0 | 70,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2015-04-30 | 2015-04-30 | 5,000 | $3.25 | $16.3K | 25,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2015-04-27 | 2015-04-28 | 15,000 | $3.71 | $55.6K | 20,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2015-03-27 | 2015-03-30 | 5,000 | $4.17 | $20.9K | 5,000 | SEC↗ |